CJC-1295 (no DAC) + Ipamorelin (Blend)

CJC-1295 (no DAC) and Ipamorelin are studied together for their potential to enhance natural growth hormone release through dual pathways—mimicking the body’s physiologic rhythm without impacting cortisol or prolactin.
CJC-1295 (no DAC) and Ipamorelin are not FDA-approved for combined therapeutic use and are classified as research peptides. This content is intended for educational and informational purposes only.

What is CJC-1295 (no DAC) + Ipamorelin (Blend)?

CJC-1295 without Drug Affinity Complex (no DAC) is a synthetic analog of growth hormone–releasing hormone (GHRH) that stimulates the pituitary gland to naturally release growth hormone (GH) in short, physiologic pulses. Unlike the DAC version, the no DAC form has a much shorter half-life, allowing GH release patterns to more closely mimic the body’s natural rhythm. Ipamorelin is a selective growth hormone secretagogue (GHS) and ghrelin receptor agonist that increases GH secretion without significantly affecting cortisol or prolactin. When studied together, these peptides may have complementary effects on GH output and recovery.


Mechanisms of Action

CJC-1295 (no DAC) + Ipamorelin may work together by:

  • CJC-1295 (no DAC): Binding to GHRH receptors to boost GH pulse amplitude and frequency in a short-acting, natural pattern
  • Ipamorelin: Activating ghrelin receptors (GHS-R1a) to enhance GH pulses without unwanted hormone spikes
  • Increasing circulating IGF-1 to support protein synthesis, tissue repair, and metabolic regulation
  • Supporting lean muscle preservation, connective tissue health, and fat metabolism in research models
  • Enhancing overall GH output by combining two distinct hormone stimulation pathways
This blend contains

Research Highlights

Research on

CJC-1295 (No DAC)

Mimics Natural, Pulsatile GH Secretion

CJC‑1295 without DAC is a short-acting analog of GHRH that reproduces the body’s natural growth hormone (GH) pulse patterns, with a half-life of around 30 minutes.

Source: pep-pedia

Precise Control Without Receptor Desensitization

Its short duration allows for frequent administration that avoids pituitary down-regulation—a key advantage for maintaining physiologic GH sensitivity.

Source: hkroids

Rapid GH Response & IGF‑1 Pathway Activation

Used in conjunction with GHRP peptides like Ipamorelin, CJC‑1295 (no DAC) can enhance GH pulse amplitude and stimulate downstream IGF‑1 signaling for anabolic effects.

Source: thepeptidereport

Clinical Potential in Muscle Growth, Fat Metabolism & Aging

Clinical and preclinical studies have linked CJC‑1295 (general notes across versions) to increases in GH/IGF‑1, improvements in body composition, sleep, and anti-aging markers—though human data remains limited for No DAC specifically.

Source: peptideinstitute
Research on

Ipamorelin

Selective GH Secretagogue (GHS‑R1a Agonist)

Ipamorelin binds specifically to the ghrelin receptors in the pituitary, inducing growth hormone (GH) release without significantly impacting cortisol, ACTH, or prolactin—offering a cleaner profile compared to other GHRPs.

Source: pep-pedia

Musculoskeletal Support & Bone Health

Animal studies indicate that Ipamorelin may counteract glucocorticoid-induced muscle catabolism and increase bone mineral content, particularly enhancing tibial growth and bone density in female rats.

Source: sagepub

Precise, Pulsatile GH Release

Ipamorelin closely mimics natural GH secretion patterns by delivering targeted pulses, which helps maintain physiological hormone balance and potentially improves metabolic responses.

Source: propeptidesource

Potential Anti-Aging & Recovery Applications

Due to its selectivity and minimal hormonal side effects, Ipamorelin is under investigation as a research tool for muscle recovery, anti-aging protocols, and metabolic studies.

Source: regentherapy

Molecular Structure

CJC-1295 (No DAC)

Sequence

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser

Molecular Formula

C₁₅₂H₂₅₂N₄₄O₄₂

Molecular Weight

3367.88 g/mol

Source
PubChem

Ipamorelin

Sequence

Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (Aib = 2-aminoisobutyric acid, 2-Nal = 2-naphthylalanine)

Molecular Formula

C₃₈H₄₉N₉O₅

Molecular Weight

711.86 g/mol

Source
PubChem

Sources